Objective To evaluate cervical cancer screening with primary human papillomavirus (HPV) testing in Mozambique, a country with one of the highest burdens of cervical cancer globally. Methods Women aged 30–49 years were prospectively enrolled and offered primary HPV testing using either self- collected o...
Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL® hereafter referred to as GARDASIL-4) and two other vaccines (CECOLIN® and CER...
There is limited information on the prevalence of sexually transmitted infections and the prevalence of cervical neoplasia in rural sub-Saharan Africa. This study describes the prevalence and the etiology of STIs and the prevalence of cervical neoplasia among women in southern Mozambique. An age-stratifi...
Sub-Saharan Africa concentrates the largest burden of cervical cancer worldwide. The introduction of the HPV vaccination in this region is urgent and strategic to meet global health targets. This was a cross-sectional study conducted in Mozambique prior to the first round of the HPV vaccine demonstration...
Em Moçambique, o cancro do colo do útero corresponde a cerca de um terço dos casos de cancro na mulher, reflectin da elevada prevalência de infecção pelo Vírus do Papiloma Humano (Human papillomavirus – HPV). Actualmente, todas as províncias são abrangidas por um programa de rastreio por inspe...
Em Moçambique, o cancro do colo do útero corresponde a cerca de um terço dos casos de cancro na mulher, reflectindo a elevada prevalência de infecção peloVírus do Papiloma Humano (Human papillomavirus – HPV). Actualmente, todas as províncias são abrangidas por um programa de rastreio por inspe...
